THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 113 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,737 | -21.8% | 47,710 | -6.2% | 0.00% | – |
| Q2 2023 | $526,442 | -77.2% | 50,864 | -76.1% | 0.00% | – |
| Q1 2023 | $2,306,000 | +96023.4% | 212,527 | -0.6% | 0.00% | – |
| Q4 2022 | $2,399 | -99.9% | 213,848 | +6.9% | 0.00% | – |
| Q3 2022 | $2,030,000 | +8.0% | 200,113 | -3.5% | 0.00% | – |
| Q2 2022 | $1,879,000 | +13.5% | 207,355 | +19.7% | 0.00% | – |
| Q1 2022 | $1,656,000 | -27.0% | 173,292 | -15.5% | 0.00% | – |
| Q4 2021 | $2,267,000 | +31.3% | 205,110 | -12.1% | 0.00% | – |
| Q3 2021 | $1,726,000 | +235.1% | 233,269 | +558.1% | 0.00% | – |
| Q2 2021 | $515,000 | -12.3% | 35,448 | +23.3% | 0.00% | – |
| Q1 2021 | $587,000 | -9.4% | 28,752 | -21.3% | 0.00% | – |
| Q4 2020 | $648,000 | +151.2% | 36,515 | +113.0% | 0.00% | – |
| Q3 2020 | $258,000 | -20.9% | 17,147 | +10.4% | 0.00% | – |
| Q2 2020 | $326,000 | -10.9% | 15,536 | -1.9% | 0.00% | – |
| Q1 2020 | $366,000 | -1.6% | 15,842 | +10.2% | 0.00% | – |
| Q4 2019 | $372,000 | +10.4% | 14,382 | -17.0% | 0.00% | – |
| Q3 2019 | $337,000 | -77.2% | 17,332 | -81.3% | 0.00% | – |
| Q2 2019 | $1,477,000 | -67.4% | 92,483 | -53.7% | 0.00% | -100.0% |
| Q1 2019 | $4,530,000 | +27.2% | 199,845 | +43.6% | 0.00% | 0.0% |
| Q4 2018 | $3,560,000 | +815.2% | 139,145 | +1068.8% | 0.00% | – |
| Q3 2018 | $389,000 | +97.5% | 11,905 | +36.8% | 0.00% | – |
| Q2 2018 | $197,000 | -17.9% | 8,703 | -12.0% | 0.00% | – |
| Q1 2018 | $240,000 | -15.5% | 9,892 | -2.8% | 0.00% | – |
| Q4 2017 | $284,000 | -79.3% | 10,181 | -74.2% | 0.00% | – |
| Q3 2017 | $1,369,000 | -15.1% | 39,494 | -2.4% | 0.00% | – |
| Q2 2017 | $1,612,000 | -6.6% | 40,474 | -13.7% | 0.00% | – |
| Q1 2017 | $1,726,000 | -40.5% | 46,887 | -48.5% | 0.00% | -100.0% |
| Q4 2016 | $2,901,000 | +84.0% | 90,976 | +109.1% | 0.00% | – |
| Q3 2016 | $1,577,000 | +78750.0% | 43,500 | +39808.3% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 109 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 109 | -58.1% | 0.00% | – |
| Q4 2015 | $4,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |